Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


3rd Annual

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


CLL-Lymphoma

US Focus Meeting

Updating Knowledge & Clinical Practice in 2024


Register / Login to view content


Estancia La Jolla Hotel, La Jolla, California

Friday, May 3, 2024 - Saturday, May 4, 2024

Presentations will be available online for 12 months

Meeting content distributed to 12,000+ HCPs

For more information get in touch!

=

Co-chair

Susan O’Brien, MD

University of California, Irvine Medical Center, California

=

Co-chair

Christopher Flowers, MD

MD Anderson Cancer Center, Texas

Dear Colleagues and Friends,


We are delighted to have hosted the CLL-Lymphoma US Focus Meeting 2024, multinational congress at Estancia La Jolla Hotel, La Jolla, California on the 3rd of May, 2024 to the 4th of May, 2024.


This congress served as a pivotal platform for collaboration, advancing research and enhancing patient care.


For those who could not attend, all congress content is available online and will remain accessible for a full year, allowing healthcare professionals worldwide to benefit from the insights shared.


People stood in a circle, smiling, with a cup of water

Agenda & Faculty

CLL-Lymphoma US Focus Meeting, Friday, May 3, 2024 - Saturday, May 4, 2024

7:00 AM

Registration Opens

8:00 AM

Product Theatre supported by AbbVie

9:00 AM

Coffee Break

9:30 AM

Opening Remarks – Ryan Fitzpatrick, CEO, MD Education

Session 1

9:35 AM

Clonal Heterogeneity in CLL and opportunities for immune targeting

=

Catherine Wu, MD

Dana-Farber Cancer Institute, Massachusetts

9:55 AM

How I choose which frontline treatment I use in which patient

=

Matthew Davids, MD

Dana-Farber Cancer Institute, Massachusetts

10:15 AM

Interesting/Unusual Cases in CLL

=

Alessandra Ferrajoli, MD

MD Anderson Cancer Center, Houston, Texas

10:35 AM

Panel Discussion

10:55 AM

Coffee Break

Session 2

11:15 AM

Small molecule combinations

=

John Allan, MD

Weill Cornell Medicine, New York

11:35 AM

MRD in CLL, is it ready for use in practice?

=

Neil Kay, MD

Mayo Clinic, Minnesota

11:55 AM

Debate: BTKi or VenG for non-17p deleted patients with Unmutated IGHV

=

BTKi (Prerecorded)

Nicole Lamanna, MD

Herbert Irving Comprehensive Cancer Center, New York

=

VenG

Mazyar Shadman, MD

Fred Hutchinson Cancer Center, Washington

12:35 PM

Panel Discussion

12:55 PM

Lunch Break + Group Photo

1:45 PM

Product Theatre supported by Lilly

Session 3

2:30 PM

CAR-T in CLL

=

David Maloney, MD

Fred Hutchinson Cancer Center, Washington

2:50 PM

Non-covalent BTKi

=

Catherine Coombs, MD

UCI Health, California

3:10 PM

Richter’s Syndrome, what’s on the horizon?

=

Adam Kittai, MD

Mount Sinai School of Medicine, New York

3:30 PM

Panel Discussion

3:50 PM

Coffee Break

Session 4

4:10 PM

Debate: MRD + at 1 year of VenG: Stop Therapy or continue

=

Pro stopping

Danielle Brander, MD

Duke University, North Carolina

=

Con stopping

Alexey Danilov, MD

City of Hope, California

4:50 PM

Monoclonal B cell lymphocytosis – what’s new in 2024?

=

Sameer Parikh, MD

Mayo Clinic, Minnesota

5:10 PM

CLL, Next Questions

=

John Allan, MD

Weill Cornell Medicine, New York

5:30 PM

Panel Discussion

5:50 PM

Adjourn